GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
Z

Zhejiang Shengda Bio-Pharm Co 603079.SS · CNY

Health Care · Shanghai · 🇨🇳 China

Compare

11.27

-0.53%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Zhejiang Shengda Bio-Pharm Co

Its shares trade on Shanghai under the ticker 603079.SS. It has been listed since 23 August 2017. In the fiscal year to 31 December 2025, it reported revenue of CN¥844.5m and net income of CN¥62.2m. At that date it held total assets of CN¥2.20bn and shareholders' equity of CN¥1.58bn.

Zhejiang Shengda Bio-Pharm Co., Ltd. engages in the research, development, production, and sale of food and feed additives. The company is headquartered in Taizhou, Zhejiang. The company went IPO on 2017-08-23. Its vitamin products mainly include biotin and folic acid. Its biological preservative products mainly include natamycin and nisin. The firm distributes its products in domestic market and to overseas markets.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Pharmaceuticals
Listed since
23 Aug 2017
Employees
1,152

Leadership

Pay as last reported

  • Ms. Ai HongChairman of the Board
  • Mr. Xiangxiao XuFinance Director
  • Mr. Bin ZhouGeneral Manager, since 2019
  • Mr. Jianxin XuDeputy General Manager, Director, since 2013
  • Ms. Jing ZhuDeputy General Manager, Director, since 2019
  • Mr. Han PangDeputy General Manager, since 2018
  • Ms. Yi-Xuan ZhuSecretary of the Board
  • Mr. Bufei ChenDirector
  • Mr. Yonggang ZhuDirector
  • Ms. Xiqin ChenIndependent Director
  • Mr. Guohua HuIndependent Director
  • Mr. Yongquan LiIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Zhejiang Shengda Bio-Pharm employs 1152 full-time employees in Taizhou, China.
  • The company produces biotin and folic acid vitamin products for global markets.
  • Zhejiang Shengda Bio-Pharm offers natamycin and nisin biological preservatives for food and feed industries.

Weaknesses

  • Zhejiang Shengda Bio-Pharm has no presence in the Information Technology sector.
  • The company's product range is limited to food and feed additives.
  • Zhejiang Shengda Bio-Pharm does not operate in the Financials sector.

Opportunities

  • Zhejiang Shengda Bio-Pharm can expand into the Health Care industry.
  • The company can leverage its vitamin products for new markets.
  • Zhejiang Shengda Bio-Pharm can increase exports to overseas markets.

Threats

  • Zhejiang Shengda Bio-Pharm faces competition from other Health Care companies.
  • The company's reliance on vitamin and preservative products poses risks.
  • Zhejiang Shengda Bio-Pharm must navigate regulatory changes in food additives.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.